A retrospective real-world study found that full-dose Nefecon was associated with significant reductions in proteinuria and ...

Introduction: To You Who Have Been Diagnosed with IgA NephropathyIf you have been diagnosed with IgA nephropathy, have you ...

A matched comparative study of eleven patients with coexisting Alport syndrome and immunoglobulin A nephropathy identified ...

DENVER — Sefaxersen, a novel messenger RNA-targeted therapy was linked to greater reduction in proteinuria and more likely resolution of baseline hematuria vs. placebo for patients with immunoglobulin ...

Medically reviewed by Matthew Wosnitzer, MD Key Takeaways The rate of progression of immunoglobulin A nephropathy (IgAN) can vary, with many people remaining stable for decades and others progressing ...

ROCKVILLE, Md., July 20, 2026 (GLOBE NEWSWIRE)-- Today, the American Kidney Fund (AKF) and the IgA Nephrology Foundation announce the creation of a new resource for IgA nephropathy patients and their ...

Hello, this is Jinzaburo.I have been busy with my main job lately, so this is my first post in several weeks. This time, I am ...

Treatment with telitacicept significantly reduced proteinuria in patients with immunoglobulin A (IgA) nephropathy compared with placebo, according to data from a phase 3 study involving more than 300 ...

Learn about anemia in IgA nephropathy, including causes, symptoms, diagnosis, and treatment options to help manage anemia and protect kidney health.

Roughly 20% to 40% of individuals with IgA nephropathy will develop end-stage kidney disease within 20 years of diagnosis and ...

ROCKVILLE, Md., July 20, 2026 (GLOBE NEWSWIRE)-- Today, the American Kidney Fund (AKF) and the IgA Nephropathy Foundation announce the creation of a new resource for IgA nephropathy patients and their ...